RecruitingNot ApplicableNCT06786468

Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

Randomized Controlled Trial of Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

Sponsor

Mahidol University

Enrollment

104 participants

Start Date

Apr 2, 2024

Study Type

INTERVENTIONAL

Conditions

Lung Cancer (Non-Small Cell)Lung Cancer (NSCLC)

Summary

Early palliative care has been shown to improve the survival of advanced lung cancer patients. However, most of the clinical studies were performed in the era when systemic treatment options for this disease were limited. Currently, many effective treatment options are available, including targeted therapy and immunotherapy. These novel agents improve the treatment outcomes while having less toxicity compared to conventional chemotherapy. Moreover, medical oncologists are now trained to provide palliative care for patients. This study was designed to demonstrate whether early palliative care provided by the palliative care specialist still improves the quality of life or survival of advanced lung cancer patients compared to standard care provided by the medical oncologist.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether adding early specialist palliative care alongside standard cancer treatment improves quality of life and outcomes for patients with advanced non-small cell lung cancer (NSCLC). Palliative care focuses on managing symptoms and improving comfort, not just treating the cancer. **You may be eligible if...** - You are 18 or older - You have been diagnosed with advanced non-small cell lung cancer (confirmed by tissue biopsy) - You are about to start systemic treatment for lung cancer - You have some troublesome symptoms (scoring at least 4 on the Edmonton Symptom Assessment Scale) - Your physical functioning is adequate (ECOG 0-2) with expected survival over 24 weeks **You may NOT be eligible if...** - You have already received systemic treatment for advanced lung cancer - You are unable to complete questionnaires - You have too few symptoms to qualify Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREarly palliative care integration

The patients will attend palliative care clinic once a month during the first three months together with routine oncology clinic visits

DRUGStandard systemic treatment for advanced lung cancer

Standard systemic treatment for advanced lung cancer

Locations(1)

Siriraj Hospital

Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06786468

Related Trials

Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobectomy

NCT076462881 location

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT074890663 locations